what is a glp-1 medication America's Poison Centers GLP-1 Agonists: A Comprehensive Overview

Discover the transformative impact of GLP-1 agonists, originally a diabetes treatment, on thousands of peoples weight-loss journey.

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

And eventually, it may be evidence payers, clinicians, employers, and patients all start asking for.

Initially indicated for type 2 diabetes mellitus, Tirzepatide promotes glycemic control and weight loss through incretin-mediated insulin secretion and appetite suppression

Discover how GLP-1 and GLP-1/GIP therapies (semaglutide and tirzepatide) influence body composition

The findings from two clinical trials suggest that a lower dose of GLP-1 drugs, or switching to an oral pill like Foundayo, can help to maintain weight loss.